Gene editing breakthrough could offer new hope for people with phenylketonuria

Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals' genetic ancestry. PKU causes an amino acid-;called phenylalanine (Phe)-;to build up in the bloodstream.

Related Keywords

United States ,Philadelphia ,Pennsylvania ,Washington ,University Of Pennsylvania ,American ,Kiran Musunuru ,Lily Ramsey ,Rebeccac Ahrens Nicklas ,American Society Of Human Genetics ,Perelman School Of Medicine ,National Institutes Of Health ,Perelman School ,American Journal ,Human Genetics ,Genomics Advances ,American Society ,Dominique Brooks ,Cardiovascular Medicine ,National Institutes ,Gene ,Medicine ,Phenylketonuria ,Amino Acid ,Covid 19 ,Rispr ,Disability ,Na ,Gene Editing ,Enetic ,Enetics ,Genomics ,Hospital ,Laboratory ,Liver ,Newborn ,Phenylalanine ,Research ,Technology ,